β2-agonists in sports: prevalence and impact on athletic performance
Respiratory disorders caused by exercise are expressed in the development of exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA), which are observed in athletes, especially in cyclic sports, much more often than in the population. Ventilation impairments are exacerbated by i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
National Electronic Information Consortium (NEICON)
2021-12-01
|
| Series: | Спортивная медицина: наука и практика |
| Subjects: | |
| Online Access: | https://www.smjournal.ru/jour/article/view/299 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422545390927872 |
|---|---|
| author | A. A. Derevoedov A. V. Zholinsky V. S. Feshchenko I. T. Vykhodets A. A. Pavlova |
| author_facet | A. A. Derevoedov A. V. Zholinsky V. S. Feshchenko I. T. Vykhodets A. A. Pavlova |
| author_sort | A. A. Derevoedov |
| collection | DOAJ |
| description | Respiratory disorders caused by exercise are expressed in the development of exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA), which are observed in athletes, especially in cyclic sports, much more often than in the population. Ventilation impairments are exacerbated by inhaled allergens, industrial pollutants and adverse environmental conditions, which increase the risk of EIB and asthma symptoms in athletes. The use of β2-agonists can prevent or eliminate ventilation disorders, however, it requires taking into account current anti-doping rules, which allow the use of certain substances in sports without a request for therapeutic use. The studies of the influence of β2-agonists on functional indicators of athletes and sports performance do not allow to make an unambiguous conclusion about its results. Medications with β2-agonists, approved for use in sports in the form of inhalation, do not have a significant effect on the performance of athletes at major sports competitions. At the same time, the systemic use of these substances and the use of any form of terbutaline caused a positive dynamics in functional indicators, which could lead to an illegal increase in the effectiveness of sports performance. Most of the conclusions about the effect of β2-agonists on outcome are based on a small number of studies, their heterogeneity, and an insignificant number of observations. It is necessary to continue studying the effects of β2-agonists in the course of randomized clinical trials in order to individualize therapy and prevent bronchial obstruction in athletes |
| format | Article |
| id | doaj-art-f5ff6907d1124ede800386951cf945df |
| institution | Kabale University |
| issn | 2223-2524 2587-9014 |
| language | English |
| publishDate | 2021-12-01 |
| publisher | National Electronic Information Consortium (NEICON) |
| record_format | Article |
| series | Спортивная медицина: наука и практика |
| spelling | doaj-art-f5ff6907d1124ede800386951cf945df2025-08-20T03:31:02ZengNational Electronic Information Consortium (NEICON)Спортивная медицина: наука и практика2223-25242587-90142021-12-01113344210.47529/2223-2524.2021.3.6256β2-agonists in sports: prevalence and impact on athletic performanceA. A. Derevoedov0A. V. Zholinsky1V. S. Feshchenko2I. T. Vykhodets3A. A. Pavlova4Federal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyThe Federal Medical Biological AgencyFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyRespiratory disorders caused by exercise are expressed in the development of exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA), which are observed in athletes, especially in cyclic sports, much more often than in the population. Ventilation impairments are exacerbated by inhaled allergens, industrial pollutants and adverse environmental conditions, which increase the risk of EIB and asthma symptoms in athletes. The use of β2-agonists can prevent or eliminate ventilation disorders, however, it requires taking into account current anti-doping rules, which allow the use of certain substances in sports without a request for therapeutic use. The studies of the influence of β2-agonists on functional indicators of athletes and sports performance do not allow to make an unambiguous conclusion about its results. Medications with β2-agonists, approved for use in sports in the form of inhalation, do not have a significant effect on the performance of athletes at major sports competitions. At the same time, the systemic use of these substances and the use of any form of terbutaline caused a positive dynamics in functional indicators, which could lead to an illegal increase in the effectiveness of sports performance. Most of the conclusions about the effect of β2-agonists on outcome are based on a small number of studies, their heterogeneity, and an insignificant number of observations. It is necessary to continue studying the effects of β2-agonists in the course of randomized clinical trials in order to individualize therapy and prevent bronchial obstruction in athleteshttps://www.smjournal.ru/jour/article/view/299β2-agonistsrespiratory disorders in athletesrandomized clinical trialswada international standard “prohibited list” |
| spellingShingle | A. A. Derevoedov A. V. Zholinsky V. S. Feshchenko I. T. Vykhodets A. A. Pavlova β2-agonists in sports: prevalence and impact on athletic performance Спортивная медицина: наука и практика β2-agonists respiratory disorders in athletes randomized clinical trials wada international standard “prohibited list” |
| title | β2-agonists in sports: prevalence and impact on athletic performance |
| title_full | β2-agonists in sports: prevalence and impact on athletic performance |
| title_fullStr | β2-agonists in sports: prevalence and impact on athletic performance |
| title_full_unstemmed | β2-agonists in sports: prevalence and impact on athletic performance |
| title_short | β2-agonists in sports: prevalence and impact on athletic performance |
| title_sort | β2 agonists in sports prevalence and impact on athletic performance |
| topic | β2-agonists respiratory disorders in athletes randomized clinical trials wada international standard “prohibited list” |
| url | https://www.smjournal.ru/jour/article/view/299 |
| work_keys_str_mv | AT aaderevoedov b2agonistsinsportsprevalenceandimpactonathleticperformance AT avzholinsky b2agonistsinsportsprevalenceandimpactonathleticperformance AT vsfeshchenko b2agonistsinsportsprevalenceandimpactonathleticperformance AT itvykhodets b2agonistsinsportsprevalenceandimpactonathleticperformance AT aapavlova b2agonistsinsportsprevalenceandimpactonathleticperformance |